The Lebanese health ministry data and CNN’s analysis of airstrikes show that the Israeli military has dropped bombs within dangerous proximity of hospitals, which are protected under ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...
The legendary stoicism of Britons during the 1940-41 period when London and other cities were being bombed almost nightly has made them such cultural archetypes that the effects of living through ...
3, 2024. Missiles and bombs strike daily, so the city has begun on a dozen subterranean schools designed to be radiation- and bomb-proof. (AP Photo/Evgeniy Maloletka) First-graders at Gymnasium No. 6 ...
Classes continue underground at Gymnasium No. 6 despite an air alert in Zaporizhzhia, Ukraine, Sept. 3, 2024. Missiles and bombs strike daily, so the city has begun on a dozen subterranean schools ...
Biogen Inc. ( (BIIB)) has realeased its Q3 earnings. Here is a breakdown of the information Biogen Inc. presented to its investors. Biogen Inc. is a leading biotechnology company that specializes ...
Biogen’s investors are growing restless. Wednesday’s third-quarter earnings call checked most of the boxes for a successful report. The company raised its full-year ...
Despite a somewhat ambling launch, Biogen’s Eisai-partnered Alzheimer’s disease drug Leqembi continues to grow. But to truly unlock the amyloid-busting antibody’s potential, the company will ...
Biogen Raises Forecast as Alzheimer’s Drug Leqembi Shows Signs of Growth Quarterly Leqembi sales reached $67 million, beating estimates Cost cuts to drive high-teen percentage operating income boost ...
(Bloomberg) -- Biogen Inc. raised its annual earnings guidance after reporting better-than-expected third-quarter sales and profit, driven by ongoing cost-cutting measures and the strong performance ...
Biogen is the latest big biotech to make a play in protein degradation. The Massachusetts-based company has announced a deal to use Neomorph’s molecular glue degrader discovery platform to go ...
Biogen raised its annual earnings guidance after reporting better-than-expected third-quarter sales and profit, driven by ongoing cost-cutting measures and the strong performance of its new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback